Influence of perinatal conditions on C-reactive protein production. 1992

N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
Department of Pediatrics, University Hospital of Leiden, The Netherlands.

C-reactive protein rises in blood in an acute-phase response in adults, children, and neonates. In a prospective study of the influence of perinatal asphyxia, premature rupture of membranes, hyperbilirubinemia, and respiratory distress syndrome on levels of C-reactive protein in the neonate, we detected no confounding effect on the rise of C-reactive protein level in infants with these pathologic perinatal conditions, as compared with the results of a control group.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D012127 Respiratory Distress Syndrome, Newborn A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. Infantile Respiratory Distress Syndrome,Neonatal Respiratory Distress Syndrome,Respiratory Distress Syndrome, Infant
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002543 Cerebral Hemorrhage Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA. Brain Hemorrhage, Cerebral,Cerebral Parenchymal Hemorrhage,Hemorrhage, Cerebral,Intracerebral Hemorrhage,Hemorrhage, Cerebrum,Brain Hemorrhages, Cerebral,Cerebral Brain Hemorrhage,Cerebral Brain Hemorrhages,Cerebral Hemorrhages,Cerebral Parenchymal Hemorrhages,Cerebrum Hemorrhage,Cerebrum Hemorrhages,Hemorrhage, Cerebral Brain,Hemorrhage, Cerebral Parenchymal,Hemorrhage, Intracerebral,Hemorrhages, Cerebral,Hemorrhages, Cerebral Brain,Hemorrhages, Cerebral Parenchymal,Hemorrhages, Cerebrum,Hemorrhages, Intracerebral,Intracerebral Hemorrhages,Parenchymal Hemorrhage, Cerebral,Parenchymal Hemorrhages, Cerebral
D005260 Female Females
D005316 Fetal Distress A nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters. Nonreassuring Fetal Status,Fetal Status, Nonreassuring

Related Publications

N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
June 2021, Clinical chemistry and laboratory medicine,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
October 1959, Quaderni di clinica ostetrica e ginecologica,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
March 2006, Molecular immunology,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
January 1958, Duodecim; laaketieteellinen aikakauskirja,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
January 1986, Allergie und Immunologie,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
January 2011, Acta medica portuguesa,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
November 1956, La Presse medicale,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
January 1995, Thrombosis and haemostasis,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
May 1983, Molecular immunology,
N Y Schouten-Van Meeteren, and A Rietveld, and A J Moolenaar, and F Van Bel
June 2015, American journal of perinatology,
Copied contents to your clipboard!